Questioning PCOS phenotypes for reclassification and tailored therapy

Trends Endocrinol Metab. 2023 Sep 1:S1043-2760(23)00158-3. doi: 10.1016/j.tem.2023.08.005. Online ahead of print.ABSTRACTPrecise diagnoses are essential for defining appropriate treatments. This is particularly true for polycystic ovary syndrome (PCOS), whose phenotypical manifestations have recently suggested a possible diversity of etiological factors. PCOS is defined on the basis of gynecological and endocrinological alterations, but the patients often display considerable metabolic impairments, such as insulin resistance, that may worsen typical symptoms. The Rotterdam criteria fail to address this aspect, and the medical community has recently started to consider them as misleading diagnostic tools, casting doubts on whether the term PCOS is suited to describe all the clinical manifestations observed. This Opinion collects and critically discusses the scientific reports that question the definition of PCOS, calling for a revision of the current diagnostic criteria.PMID:37661546 | DOI:10.1016/j.tem.2023.08.005
Source: Trends in Endocrinology and Metabolism: TEM - Category: Endocrinology Authors: Source Type: research